Fecal Microbiomes Distinguish Patients With Autoimmune Hepatitis From Healthy Individuals

Abstract

Objective: The intestinal microbiome is associated with various autoimmune diseases. Regional difference is the main influencing factor of intestinal microbial difference. This study aimed to identify the differences in fecal microbiome between autoimmune hepatitis (AIH) patients and healthy controls (HCs) in Central China, and to validate the efficacy of fecal microbiome as a diagnostic tool for AIH. Design: We collected 115 fecal samples from AIH patients (N = 37) and HCs (N = 78) in Central China and performed gene sequencing. Fecal microbiomes were characterized and microbial markers for AIH were identified. Results: Fecal microbial diversity showed a downward trend in AIH compared with HCs. Fecal microbial communities significantly differed between both groups. At the phylum level, Verrucomicrobia abundance was significantly increased, while Lentisphaerae and Synergistetes were significantly decreased in the AIH patients vs. the HCs. Compared to the HCs, 15 genera, including Veillonella, Faecalibacterium, and Akkermansia, were enriched, while 19 genera, such as Pseudobutyrivibrio, Lachnospira, and Ruminococcaceae, were decreased in the AIH patients. Ten genera, including Veillonella, Faecalibacterium, and Akkermansia, predominated in the AIH patients. Five microbial biomarkers were deemed optimal diagnostic tools for AIH. The probability of disease was significantly increased in AIH group vs. HCs, achieving 83.25% value of area under the curve. Lou et al. Fecal Microbiome in Autoimmune Hepatitis Conclusion: We present the characteristics of AIH patients in Central China for the first time. Five microbial biomarkers, including Lachnospiraceae, Veillonella, Bacteroides, Roseburia, and Ruminococcaceae, achieved a high potential distinguishing AIH patients from HCs.

Gut Microbiome Distinguishes Patients With Epilepsy From Healthy Individuals

“…Moreover, individual microbiology is associated with many confounding factors, such as time, diet, and the environment. This has been shown in multiple studies (Ren et al, 2019(Ren et al, , 2020Lou et al, 2020;Rao et al, 2020). In particular, Ang et al (2020) conducted gene sequencing and metabolomics analysis on fecal samples and found that the structure and function of the intestinal microbial community changed significantly during ketogenesis, indicating that diet does interfere with intestinal microecology.…”

Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases

“…Lin et al [95] described, for the first time in humans, the features of a leaky gut (disruption of the architecture of the duodenal mucosa and reduced expression of tight junction proteins, such as ZO-1 and occludin) and dysbiosis, with a significant decrease of Bifidobacterium and Lactobacillus in AIH patients as compared to healthy controls. Since then, several authors have evaluated the composition of gut microbiota in AIH patients [96][97][98][99]. Similar to what was previously reported for PBC patients, Wei et al [96] identified and validated a gut microbiome signature of AIH, including four genera (Veillonella, Lactobacillus, Oscillospira, and Clostridiales) that could accurately distinguish AIH patients from healthy controls.…”

Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury

“… 14 Previous studies identified some bacterial genera that were relevant to autoimmune or alcoholic hepatitis in humans and animals using correlation analysis, such as Faecalibacterium, Veillonella, Akkmensia, Blautia, Parabacteroides and Bacteroides . 21 , 32 , 43–45 The regulatory functions of several intestinal bacterial species, such as Akkmensia muciniphila and Lactobacillus rhamnosus , in autoimmune and alcoholic liver injury were identified. 46 , 47 However, only a few species have explicit regulatory effects on autoimmune or alcoholic liver injury among the thousands of species of intestinal bacteria.…”